Evidence map›Paper›PMID 35831609›Full record

ReviewNature reviews. Immunology2023

DNA damage and repair in age-related inflammation.

Yang Zhao, Matthew Simon, Andrei Seluanov, Vera Gorbunova

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 3 pooled it
25.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 3 syntheses or guidelines pooled it, 340 citations in OpenAlex.

  1. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (TSG) fromInternational journal of molecular sciences · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Sanguinarine chloride exerts its antitumor effects on enzalutamide-resistant prostate cancer by inhibiting cell proliferation and promoting senescence via targeting AR signaling.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yang Zhao *Department of Biology, University of Rochester, Rochester, NY, USA.ORCID 0000-0002-8703-3678
Matthew Simon *Department of Biology, University of Rochester, Rochester, NY, USA.
Andrei SeluanovDepartment of Biology, University of Rochester, Rochester, NY, USA. andrei.seluanov@rochester.edu.ORCID 0000-0003-3400-538X
Vera GorbunovaDepartment of Biology, University of Rochester, Rochester, NY, USA. vera.gorbunova@rochester.edu.ORCID 0000-0001-8979-0333
University of Rochester · USFirst Affiliated Hospital Zhejiang University · CN

Funding

The role of hyaluronan in longevity and cancer resistance of longest-lived rodentP01AG047200 · NIA · UNIVERSITY OF ROCHESTER · PI Andrei Seluanov · 2014 to 2026
$36.9M
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?P01AG051449 · NIA · BROWN UNIVERSITY · PI John M Sedivy · 2016 to 2026
$30.4M
The role of SIRT6 posttranslational modifications in aging and genome stability. Supplement: Testing SIRT6 activators as potential Alzheimer's disease therapy.R01AG027237 · NIA · UNIVERSITY OF ROCHESTER · PI Vera Gorbunova · 2006 to 2026
$6.2M
Regulation of epigenome stability by SIRT6 during aging. Supplement: Does centenarian variant of SIRT6 or bowhead whale SIRT6 confer protection from Alzheimer's disease?R37AG046320 · NIA · UNIVERSITY OF ROCHESTER · PI Andrei Seluanov · 2019 to 2026
$4.7M
Comparative Analysis of DNA Break Repair in Short- and Long-Lived Rodent SpeciesR01AG031227 · NIA · UNIVERSITY OF ROCHESTER · PI GORBUNOVA, VERA · 2008 to 2012
$1.6M
The skin of naked mole rats as a model for scar-free wound healingR61AR078093 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOTCHKAREV, VLADIMIR A, GORBUNOVA, VERA · 2020 to 2021
$829k
The skin of naked mole rats as a model for scar-free wound healingR33AR078093 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOTCHKAREV, VLADIMIR A, GORBUNOVA, VERA · 2023 to 2023
$406k
NIAMS NIH HHS R33 AR078093NIAMS NIH HHS R61 AR078093NIA NIH HHS P01 AG047200NIA NIH HHS P01 AG051449NIA NIH HHS R01 AG027237NIA NIH HHS R01 AG031227NIA NIH HHS R37 AG046320
6 · The paper itself

Abstract

Genomic instability is an important driver of ageing. The accumulation of DNA damage is believed to contribute to ageing by inducing cell death, senescence and tissue dysfunction. However, emerging evidence shows that inflammation is another major consequence of DNA damage. Inflammation is a hallmark of ageing and the driver of multiple age-related diseases. Here, we review the evidence linking DNA damage, inflammation and ageing, highlighting how premature ageing syndromes are associated with inflammation. We discuss the mechanisms by which DNA damage induces inflammation, such as through activation of the cGAS-STING axis and NF-κB activation by ATM. The triggers for activation of these signalling cascades are the age-related accumulation of DNA damage, activation of transposons, cellular senescence and the accumulation of persistent R-loops. We also discuss how epigenetic changes triggered by DNA damage can lead to inflammation and ageing via redistribution of heterochromatin factors. Finally, we discuss potential interventions against age-related inflammation.

Indexed as

AgingDNA DamageCell DeathCellular SenescenceHumansInflammation

Identifiers

PMID35831609
PMCPMC10106081
OpenAlexW4285087335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.